Acyclovir Treatment for Active Genital Herpes Outbreak in Pregnancy
Oral acyclovir is safe and recommended for treating active genital herpes outbreaks during pregnancy, with standard dosing of 200 mg five times daily for 5-10 days for first episodes, or 200 mg five times daily for 5 days for recurrent episodes. 1
Treatment Regimens Based on Episode Type
First Clinical Episode During Pregnancy
- Oral acyclovir 200 mg five times daily (every 4 hours) for 5-10 days is the recommended treatment 1, 2
- Alternative: Valacyclovir 1000 mg twice daily for 5-10 days 2, 3
- Treatment should be initiated promptly upon diagnosis 3
- Virological confirmation by PCR is recommended for first episodes to distinguish from recurrent disease 3
Recurrent Episodes During Pregnancy
- Oral acyclovir 200 mg five times daily for 5 days 1, 3
- Alternative: Valacyclovir 500 mg twice daily 3
- Initiate therapy at earliest sign or symptom (prodrome) of recurrence 4
Severe or Life-Threatening Maternal HSV Infection
- Acyclovir 5 mg/kg IV every 8 hours is indicated for disseminated infection, encephalitis, pneumonitis, or hepatitis 1
- This represents a medical emergency requiring immediate treatment 1
Safety Profile in Pregnancy
Acyclovir has the most extensive safety data in pregnancy and appears safe, with no increased risk of major birth defects compared to the general population. 1, 5
- Current registry findings show no increased risk for major birth defects after acyclovir treatment 1
- Acyclovir is the first choice for HSV therapy in pregnancy due to extensive experience 5
- One case-control study suggested increased odds of gastroschisis (4.7-fold), but this had significant methodological limitations including recall bias and demographic differences 6
- Acyclovir remains FDA pregnancy category B 6
Suppressive Therapy Near Term
Daily suppressive acyclovir starting at 36 weeks gestation is recommended for women who had a first episode or recurrent genital herpes during pregnancy to reduce cesarean delivery rates and viral shedding at delivery. 6, 2, 3
- Acyclovir 400 mg three times daily from 36 weeks until delivery 6, 2, 3
- Alternative: Valacyclovir 500 mg twice daily from 36 weeks 6, 3
- This regimen reduces clinical recurrences at delivery, viral shedding, and cesarean delivery rates 6, 7
- In one randomized trial, 0% of acyclovir-treated patients versus 36% of placebo patients required cesarean for herpes recurrence 7
Critical Management Considerations
Timing of First Episode Matters for Delivery Planning
- Risk of neonatal transmission is 30-50% if first episode occurs near delivery 1
- Risk is only 1-3% for recurrent herpes at term 1, 3
- Cesarean delivery is recommended if first episode occurs less than 6 weeks before delivery 2, 3
- Cesarean delivery is recommended if active lesions or prodrome present at labor onset 1, 5, 3
HIV Testing
- All pregnant women with first episode genital herpes should be tested for HIV if not previously done 2
- This is critical as HSV/HIV coinfection increases transmission risks 5
Monitoring and Follow-up
- Women receiving acyclovir during pregnancy should be reported to the pregnancy registry (historically maintained by manufacturer in cooperation with CDC) 1
- Viral cultures during pregnancy do not predict shedding at delivery and are not routinely indicated 1
Common Pitfalls to Avoid
- Do not withhold acyclovir treatment due to pregnancy concerns - the safety profile is well-established and benefits outweigh theoretical risks 1, 5
- Do not rely on viral cultures to predict delivery management - clinical examination at labor onset is what matters 1
- Do not assume all genital lesions in pregnancy are recurrences - first episodes require virological confirmation and have dramatically different neonatal transmission risks 3
- Do not forget suppressive therapy at 36 weeks - this single intervention significantly reduces cesarean delivery rates 6, 7